Flare Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Flare Therapeutics's estimated annual revenue is currently $5.2M per year.
- Flare Therapeutics's estimated revenue per employee is $77,500
Employee Data
- Flare Therapeutics has 67 Employees.
- Flare Therapeutics grew their employee count by 10% last year.
Flare Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Scientific Officer, Co-founder | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Development Officer (CDO) | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | COO & CFO | Reveal Email/Phone |
6 | Interim Chief People Officer | Reveal Email/Phone |
7 | Head Computational Biology | Reveal Email/Phone |
8 | VP, Medicinal Chemistry | Reveal Email/Phone |
9 | VP, Biology | Reveal Email/Phone |
10 | VP, Biochemistry and Chemical Biology | Reveal Email/Phone |
Flare Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Flare Therapeutics?
Our team ‘brings it’ every day for one mission: to conquer transcription factors and create cutting-edge medicines for patients. Flare is lighting up a new therapeutic space with an entirely different approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of our scientific founders, Flare’s team is leveraging the power of ‘switch sites’ as druggable regions that hold the control for predictable and profound changes in DNA transcription, and therefore, gene expression. Our drug discovery to target ‘switch sites’ has rapidly advanced, resulting in our pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology.
keywords:N/A
N/A
Total Funding
67
Number of Employees
$5.2M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M |
#2 | $17.5M | 67 | 2% | N/A |
#3 | $7.5M | 67 | -1% | N/A |
#4 | $7.9M | 67 | N/A | N/A |
#5 | $19.1M | 67 | -35% | $17.7M |